secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rani Therapeutics Holdings, Inc. (RANI)
CIK:        0001856725
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0000950170-25-064624
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rani Therapeutics receives Nasdaq deficiency notice for MVLS below $50M
-----------------------------------------------------------------------

- Nasdaq notified Rani on May 1, 2025 that its Market Value of Listed Securities was below $50M for 30 consecutive business days.
- Company has 180 calendar days, until October 28, 2025, to regain compliance by achieving MVLS >= $50M for 10 consecutive business days.
- If noncompliance persists, Nasdaq may delist; Rani could appeal or apply to transfer to Nasdaq Capital Market.
- Rani is considering actions to regain compliance but has not yet decided on a response.
- There is no assurance of regaining compliance or meeting other listing criteria.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1856725/000095017025064624/0000950170-25-064624-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1856725/000095017025064624/rani-20250501.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-064624

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer